From July 1, 2021 to September 30, 2021, the company has repurchased 3,293,161 shares, representing 1.27% for $642.2 million. With this, the company has completed the repurchase of 3,293,161 shares, representing 1.27% for $642.2 million under the buyback announced on June 24, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
400.2 USD | -0.49% | -0.15% | -1.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B | |
+307.09% | 8.43B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Tranche Update on Vertex Pharmaceuticals Incorporated's Equity Buyback Plan announced on June 24, 2021.